Suven Life Sciences Ltd.

View in App
82.80 -0.15 ▼-0.2%

11 December 2023, 01:51:59 PM
Volume: 256,394

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.suven.com
Market Cap 1,802.38 Cr.
Enterprise Value(EV) 1,683.43 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -5.30 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 15.52 Trailing Twelve Months Ending 2023-09
Price to Book Value 5.33 Calculated using Price: 82.65
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 21.81 Cr. 218,073,717 Shares
FaceValue 1
About Suven Life Sciences Ltd.
Suven Life Sciences was promoted by Mrs. and Mr. Venkat Jasti in 1989, as a Private Limited Company. Later it was converted into a Public Limited Company in January 1995.

Suven Life Sciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Suven Life Sciences Ltd. Performance

View details >>
1 Day
-0.18%
1 Week
-1.49%
1 Month
+0.30%
3 Month
+25.93%
6 Month
+37.66%
1 Year
+28.97%
2 Year
-2.31%
5 Year
-61.10%
10 Year
+29.21%

Suven Life Sciences Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 32.91 12.50 13.81 17.25 -4.75 -49.27 -67.29 -145.90 -50.17
Return on Capital Employed (%) 37.93 15.43 18.19 26.01 0.40 -54.67 -60.09 -117.81 -49.89
Return on Assets (%) 22.38 8.87 9.97 12.84 -3.31 -27.07 -28.99 -57.51 -34.54

Suven Life Sciences Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 559 595 667 767 239 143 108 96 375 338
Non Curr. Liab. 86 41 28 30 25 12 5 4 2 2
Curr. Liab. 127 211 208 226 157 120 110 102 105 10
Minority Int.
Equity & Liab. 773 846 903 1,023 421 275 222 202 483 350
Non Curr. Assets 291 319 322 350 22 116 26 41 137 134
Curr. Assets 477 528 581 674 398 160 197 160 345 216
Misc. Exp. not W/O 5
Total Assets 773 846 903 1,023 421 275 222 202 483 350

Suven Life Sciences Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 521 500 544 625 286 14 13 12 14 12
Other Income 9 20 21 23 27 14 8 2 8 19
Total Income 529 519 565 649 313 28 21 13 22 31
Total Expenditure -361 -398 -414 -424 -297 -130 -93 -134 -139 -147
PBIDT 168 121 150 225 16 -102 -72 -121 -117 -116
Interest -5 -6 -6 -5 -2 -1 -1 -1 -1 0
Depreciation -12 -18 -21 -25 -14 -4 -4 -4 -7 -7
Taxation -43 -26 -36 -72 -24 12 5
Exceptional Items 4 6 7
PAT 109 72 87 124 -24 -94 -72 -122 -118 -116
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 109 72 87 124 -24 -94 -72 -122 -118 -116
Adjusted EPS 8 5 6 9 -2 -7 -5 -8 -5 -5

Suven Life Sciences Ltd. Cash Flow

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 143 68 109 70 -53 -135 -96 -128 -103
Cash Fr. Inv. -110 -39 -311 -1 37 146 56 -22 -261
Cash Fr. Finan. 179 -68 -30 -52 5 3 35 146 396
Net Change 212 -39 -232 17 -11 14 -5 -4 32
Cash & Cash Eqvt 279 241 9 26 0 15 9 5 37

Suven Life Sciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 60.00 60.00 64.98 64.98 64.98 69.57 69.57 69.57 69.57
Public 40.00 40.00 35.02 35.02 35.02 30.43 30.43 30.43 30.43
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Suven Life Sciences Ltd. Announcements

View details >>
Fri, 01 Dec 2023
Copy of Newspaper Publication
Suven Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication
Fri, 10 Nov 2023
Monitoring Agency Report
Report of the Monitoring Agency with respect to utilization of proceeds of the Rights Issue for the quarter ended 30th September, 2023
Tue, 07 Nov 2023
Copy of Newspaper Publication
Suven Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication

Suven Life Sciences Ltd. Technical Scans

View details >>
Fri, 08 Dec 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
MFI Trending Down MFI Trending Down
ROC Trending Down ROC Trending Down

Suven Life Sciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,236.80 +0.1%
Cipla Ltd. 98,444.27 1,196.90 -1.8%
Divi's Laboratories Ltd. 97,728.28 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,533.00 -0.4%
Mankind Pharma Ltd. 78,250.95 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. 69,508.23 2,072.85 +0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,236.80 +0.1%
Cipla Ltd. Consolidated 2023-09 28.51 1,196.90 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,533.00 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,072.85 +0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,236.80 +0.1%
Cipla Ltd. Consolidated 2023-09 3.97 1,196.90 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,533.00 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,072.85 +0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,236.80 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,196.90 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,533.00 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,072.85 +0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,236.80 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,196.90 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,533.00 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,072.85 +0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,236.80 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,196.90 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,533.00 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,072.85 +0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,236.80 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,196.90 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,533.00 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,072.85 +0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,236.80 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,196.90 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,656.45 -0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,447.55 -5.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,533.00 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,913.10 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,072.85 +0.9%

Suven Life Sciences Ltd. FAQ's

What is Suven Life Sciences share price?
Can I buy Suven Life Sciences shares now?
What is the Market Cap of Suven Life Sciences?
What are the key metrics to analyse Suven Life Sciences?
What is the 52 Week High and Low of Suven Life Sciences?
What is the trend of Suven Life Sciences share price?